be_ixf;ym_202411 d_25; ct_50

Latest Insights on SPR

new normal companies to invest in Welcome to the New Normal (3-minute read) Businesses need to adapt to our constantly changing world. And I recently revealed which ones will be the winners throughout the pandemic and beyond…
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.
Unusual Options Activity: A Black Friday Shopping Spree Unusual Options Activity: A Black Friday Shopping Spree As the market panicked in response to the Omicron variant, Big Money poured millions into bullish bets on individual stocks...
Making Sense of Price Moves With Greeks Making Sense of Price Moves With Greeks Mike Carr wraps up his crash course on options Greeks, showing how gamma, vega, and theta can be used to make sense of price moves.
Happy Thanksgiving From the True Options Team Happy Thanksgiving From the True Options Team! Happy Thanksgiving True Options Masters! We appreciate all of your support since our launch in May. Here's how our team is celebrating...

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“Loving this. Should have started a long time ago.”

- Jay

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This